Gain Therapeutics GANX
NASDAQ GANX
$1.29 +0.10 (+8.40%)
At close: Oct 22, 2026 · 4:00 PM EDT

Gain Therapeutics (GANX) Change in Receivables (2020 - 2021)

Updated

Gain Therapeutics (GANX) reported Change in Receivables of -$24,429 for Q4 2021, compared with $6,687 a year earlier.

Analysis

Gain Therapeutics (GANX) Change in Receivables (2020 - 2021) Analysis & Trends

For FY2021, Gain Therapeutics posted Change in Receivables of -$8,264.

  • By year, Change in Receivables came in at $196.00 in FY2020.
  • Five-year quarterly Change in Receivables spans a low of -$328,453 in Q3 2021 and a high of $513,738 in Q1 2021.
  • Per Business Quant data, the three quarters before Q4 2021 came in at -$328,453 (Q3 2021), -$169,120 (Q2 2021) and $513,738 (Q1 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -188.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 1.37 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 1.09 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 333.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Gain Therapeutics 54.89 Mn -4.40 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -24,429.00
Sep 30, 2021 -328,453.00
Jun 30, 2021 -169,120.00
Mar 31, 2021 513,738.00
Dec 31, 2020 6,687.00
Sep 30, 2020 -107,220.00
Jun 30, 2020 163,676.00
Mar 31, 2020 -62,947.00
API Access

Gain Therapeutics Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=GANX&period=max&api_key=YOUR_API_KEY